Kintara Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Selling, General & Admin	5.49	7.51	9.76	4.51	4.74	4.04	3.32	2.85	2.17	3.13	Upgrade
Research & Development	9.31	15.17	11.82	3.63	3.66	7.13	5	3.36	2.56	2.12	Upgrade
Other Operating Expenses	0	0	16.59	1.05	0	0	0	0	0	0	Upgrade
Operating Expenses	14.8	22.68	38.17	9.2	8.4	11.17	8.32	6.21	4.72	5.25	Upgrade
Operating Income	-14.8	-22.68	-38.17	-9.2	-8.4	-11.17	-8.32	-6.21	-4.72	-5.25	Upgrade
Interest Expense / Income	-0.14	-0.01	0.03	-0.08	0	0	0	0	0	0.01	Upgrade
Other Expense / Income	-0.01	-0.01	0.11	0	-0.35	-0.04	-0.24	2.65	-0.38	-11.62	Upgrade
Pretax Income	-14.65	-22.66	-38.3	-9.13	-8.05	-11.14	-8.08	-8.86	-4.35	6.36	Upgrade
Net Income	-14.65	-22.66	-38.3	-9.13	-8.05	-11.14	-8.08	-8.86	-4.35	6.36	Upgrade
Preferred Dividends	0.37	2.47	3.21	0.02	0.08	0.18	0.79	0.24	0	0	Upgrade
Net Income Common	-15.02	-25.13	-41.5	-9.14	-8.13	-11.31	-8.87	-9.1	-4.35	6.36	Upgrade
Shares Outstanding (Basic)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Change	66.32%	88.13%	147.86%	305.64%	23.42%	73.17%	10.03%	15.04%	-2.61%	31.76%	Upgrade
EPS (Basic)	-9.27	-25.80	-80.00	-43.50	-158.00	-271.00	-370.00	-415.00	-230.00	-400.00	Upgrade
EPS (Diluted)	-9.27	-25.80	-80.00	-43.50	-158.00	-271.00	-370.00	-415.00	-230.00	-	Upgrade
Free Cash Flow	-12.1	-20.39	-18.87	-7.93	-6.33	-9.86	-8.04	-5.16	-3.85	-4	Upgrade
Free Cash Flow Per Share	-7.47	-20.94	-36.44	-37.95	-122.88	-236.41	-333.69	-235.77	-202.43	-250.49	Upgrade
EBITDA	-14.73	-22.62	-38.24	-9.19	-8.03	-11.11	-8.07	-8.85	-4.35	6.37	Upgrade
Depreciation & Amortization	0.06	0.06	0.03	0.01	0.02	0.02	0.02	0.01	0	0	Upgrade
EBIT	-14.79	-22.68	-38.27	-9.2	-8.05	-11.14	-8.08	-8.86	-4.35	6.37	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).